J. Banchereau and R. M. Steinman, Dendritic cells and the control of immunity, Nature, vol.392, issue.6673, pp.245-252, 1998.
DOI : 10.1038/32588

C. G. Figdor, I. J. De-vries, W. J. Lesterhuis, and C. J. Melief, Dendritic cell immunotherapy: mapping the way, Nature Medicine, vol.10, issue.5, pp.475-480, 2004.
DOI : 10.1038/nm1039

R. M. Steinman and J. Banchereau, Taking dendritic cells into medicine, Nature, vol.204, issue.7161, pp.419-426, 2007.
DOI : 10.1038/nature06175

S. A. Rosenberg, J. C. Yang, and N. P. Restifo, Cancer immunotherapy: moving beyond current vaccines, Nature Medicine, vol.8, issue.9, pp.909-915, 2004.
DOI : 10.1002/1097-0215(20001015)88:2<232::AID-IJC14>3.3.CO;2-#

G. J. Adema, Dendritic cells from bench to bedside and back, Immunology Letters, vol.122, issue.2, pp.128-130, 2009.
DOI : 10.1016/j.imlet.2008.11.017

D. Vries, I. J. , D. J. Krooshoop, N. M. Scharenborg, W. J. Lesterhuis et al., Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state, Cancer Res, vol.63, pp.12-17, 2003.

N. Janikashvili, N. Larmonier, and E. Katsanis, Personalized dendritic cell-based tumor immunotherapy, Immunotherapy, vol.2, issue.1, pp.57-68, 2010.
DOI : 10.2217/imt.09.78

C. W. Chan, E. Crafton, H. N. Fan, J. Flook, K. Yoshimura et al., Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity, Nature Medicine, vol.12, issue.2, pp.207-213, 2006.
DOI : 10.1038/nm1352

J. Fraszczak, M. Trad, N. Janikashvili, D. Cathelin, D. Lakomy et al., Peroxynitrite-Dependent Killing of Cancer Cells and Presentation of Released Tumor Antigens by Activated Dendritic Cells, The Journal of Immunology, vol.184, issue.4, pp.1876-1884, 2010.
DOI : 10.4049/jimmunol.0900831

J. Huang, T. Tatsumi, E. Pizzoferrato, N. Vujanovic, and W. J. Storkus, Nitric Oxide Sensitizes Tumor Cells to Dendritic Cell-Mediated Apoptosis, Uptake, and Cross-Presentation, Cancer Research, vol.65, issue.18, pp.8461-8470, 2005.
DOI : 10.1158/0008-5472.CAN-05-0654

N. Larmonier, J. Fraszczak, D. Lakomy, B. Bonnotte, and E. Katsanis, Killer dendritic cells and their potential for cancer immunotherapy, Cancer Immunology, Immunotherapy, vol.115, issue.1, pp.1-11, 2010.
DOI : 10.1007/s00262-009-0736-1

N. V. Serbina, T. P. Salazar-mather, C. A. Biron, W. A. Kuziel, and E. G. Pamer, TNF/iNOS-Producing Dendritic Cells Mediate Innate Immune Defense against Bacterial Infection, Immunity, vol.19, issue.1, pp.59-70, 2003.
DOI : 10.1016/S1074-7613(03)00171-7

J. Taieb, N. Chaput, C. Ménard, L. Apetoh, E. Ullrich et al., A novel dendritic cell subset involved in tumor immunosurveillance, Nature Medicine, vol.167, issue.2, pp.214-219, 2006.
DOI : 10.1038/nm1356
URL : https://hal.archives-ouvertes.fr/hal-00080612

T. Tatsumi, J. Huang, W. E. Gooding, A. Gambotto, P. D. Robbins et al., Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity, Cancer Res, vol.63, pp.6378-6386, 2003.

R. Alli, B. Savithri, S. Das, C. Varalakshmi, N. Rangaraj et al., Involvement of NKR-P2/NKG2D in DC-mediated killing of tumor targets: indicative of a common, innate, target-recognition paradigm?, European Journal of Immunology, vol.34, issue.4, pp.1119-1126, 2004.
DOI : 10.1002/eji.200324793

C. Chauvin and R. Josien, Dendritic Cells as Killers: Mechanistic Aspects and Potential Roles, The Journal of Immunology, vol.181, issue.1, pp.11-16, 2008.
DOI : 10.4049/jimmunol.181.1.11

C. Chauvin, J. M. Philippeau, C. Hémont, F. X. Hubert, Y. Wittrant et al., Killer Dendritic Cells Link Innate and Adaptive Immunity against Established Osteosarcoma in Rats, Cancer Research, vol.68, issue.22, pp.9433-9440, 2008.
DOI : 10.1158/0008-5472.CAN-08-0104

R. Josien, M. Heslan, J. P. Soulillou, and M. C. Cuturi, -dependent Mechanism, The Journal of Experimental Medicine, vol.7, issue.3, pp.467-472, 1997.
DOI : 10.1146/annurev.immunol.14.1.619
URL : https://hal.archives-ouvertes.fr/ineris-00972216

A. Nicolas, D. Cathelin, N. Larmonier, J. Fraszczak, P. E. Puig et al., Dendritic Cells Trigger Tumor Cell Death by a Nitric Oxide-Dependent Mechanism, The Journal of Immunology, vol.179, issue.2, pp.812-818, 2007.
DOI : 10.4049/jimmunol.179.2.812

R. M. Srivastava, . Ch, A. Varalakshmi, and . Khar, Cross-linking a mAb to NKR-P2/NKG2D on dendritic cells induces their activation and maturation leading to enhanced anti-tumor immune response, International Immunology, vol.19, issue.5, pp.591-607, 2007.
DOI : 10.1093/intimm/dxm024

B. Trinité, C. Chauvin, H. Pêche, C. Voisine, M. Heslan et al., Immature CD4-CD103+ Rat Dendritic Cells Induce Rapid Caspase-Independent Apoptosis-Like Cell Death in Various Tumor and Nontumor Cells and Phagocytose Their Victims, The Journal of Immunology, vol.175, issue.4, pp.2408-2417, 2005.
DOI : 10.4049/jimmunol.175.4.2408

B. Trinité, C. Voisine, H. Yagita, and R. Josien, A Subset of Cytolytic Dendritic Cells in Rat, The Journal of Immunology, vol.165, issue.8, pp.4202-4208, 2000.
DOI : 10.4049/jimmunol.165.8.4202

F. M. Ayres, M. Narita, M. Takahashi, L. Alldawi, A. Liu et al., Cr???Release Assay to Assess the Cytotoxicity of Dendritic Cells on Hematopoietic Tumor Cells, Immunological Investigations, vol.210, issue.4, pp.219-227, 2003.
DOI : 10.1016/0022-1759(91)90325-A

F. M. Ayres, M. Narita, M. Takahashi, T. Yano, A. Liu et al., Human dendritic cells mediate anti-tumor activity against hematopoietic tumor cells without direct contact and Fas/FasL killing pathway, Oncology Reports, vol.11, pp.1017-1023, 2004.
DOI : 10.3892/or.11.5.1017

S. Beaulieu, M. Lafontaine, M. Richer, I. Courchesne, E. A. Cohen et al., Characterization of the Cytotoxic Factor(s) Released from Thymic Dendritic Cells upon Human Immunodeficiency Virus Type 1 Infection, Virology, vol.241, issue.2, pp.285-297, 1998.
DOI : 10.1006/viro.1997.8977

L. Chaperot, A. Blum, O. Manches, G. Lui, J. Angel et al., Virus or TLR Agonists Induce TRAIL-Mediated Cytotoxic Activity of Plasmacytoid Dendritic Cells, The Journal of Immunology, vol.176, issue.1, pp.248-255, 2006.
DOI : 10.4049/jimmunol.176.1.248
URL : https://hal.archives-ouvertes.fr/inserm-00286442

A. I. Chapoval, K. Tamada, and L. Chen, In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells, Blood, vol.95, pp.2346-2351, 2000.

N. A. Fanger, C. R. Maliszewski, K. Schooley, and T. S. Griffith, Human Dendritic Cells Mediate Cellular Apoptosis via Tumor Necrosis Factor???Related Apoptosis-Inducing Ligand (Trail), The Journal of Experimental Medicine, vol.158, issue.8, pp.1155-1164, 1999.
DOI : 10.1126/science.1352913

A. W. Hardy, D. R. Graham, G. M. Shearer, and J. P. Herbeuval, HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-??, Proc. Natl. Acad. Sci. USA, pp.17453-17458, 2007.
DOI : 10.1073/pnas.0707244104
URL : https://hal.archives-ouvertes.fr/hal-00177945

K. S. Hill, F. Errington, L. P. Steele, A. Merrick, R. Morgan et al., OK432-Activated Human Dendritic Cells Kill Tumor Cells via CD40/CD40 Ligand Interactions, The Journal of Immunology, vol.181, issue.5, pp.3108-3115, 2008.
DOI : 10.4049/jimmunol.181.5.3108

P. Hubert, S. L. Giannini, A. Vanderplasschen, E. Franzen-detrooz, N. Jacobs et al., Dendritic cells induce the death of human papillomavirus transformed keratinocytes, The FASEB Journal, vol.15, pp.2521-2523, 2001.
DOI : 10.1096/fj.00-0872fje

B. M. Janjic, G. Lu, A. Pimenov, T. L. Whiteside, W. J. Storkus et al., Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. I. Involvement of an Apoptosis-Inducing Pathway, The Journal of Immunology, vol.168, issue.4, pp.1823-1830, 2002.
DOI : 10.4049/jimmunol.168.4.1823

H. G. Joo, T. P. Fleming, Y. Tanaka, T. J. Dunn, D. C. Linehan et al., Human dendritic cells induce tumor-specific apoptosis by soluble factors, International Journal of Cancer, vol.30, issue.1, pp.20-28, 2002.
DOI : 10.1002/ijc.10656

M. Lichtner, C. Marañón, P. O. Vidalain, O. Azocar, D. Hanau et al., HIV Type 1-Infected Dendritic Cells Induce Apoptotic Death in Infected and Uninfected Primary CD4 T Lymphocytes, AIDS Research and Human Retroviruses, vol.20, issue.2, pp.175-182, 2004.
DOI : 10.1089/088922204773004897

S. Liu, Y. Yu, M. Zhang, W. Wang, and X. Cao, The Involvement of TNF-??-Related Apoptosis-Inducing Ligand in the Enhanced Cytotoxicity of IFN-??-Stimulated Human Dendritic Cells to Tumor Cells, The Journal of Immunology, vol.166, issue.9, pp.5407-5415, 2001.
DOI : 10.4049/jimmunol.166.9.5407

G. Lu, B. M. Janjic, J. Janjic, T. L. Whiteside, W. J. Storkus et al., Innate Direct Anticancer Effector Function of Human Immature Dendritic Cells. II. Role of TNF, Lymphotoxin-??1??2, Fas Ligand, and TNF-Related Apoptosis-Inducing Ligand, The Journal of Immunology, vol.168, issue.4, pp.1831-1839, 2002.
DOI : 10.4049/jimmunol.168.4.1831

P. P. Manna and T. Mohanakumar, Human dendritic cell mediated cytotoxicity against breast carcinoma cells in vitro, J. Leukoc. Biol, vol.72, pp.312-320, 2002.

M. J. Raftery, M. Schwab, S. M. Eibert, Y. Samstag, H. Walczak et al., Targeting the Function of Mature Dendritic Cells by Human Cytomegalovirus, Immunity, vol.15, issue.6, pp.997-1009, 2001.
DOI : 10.1016/S1074-7613(01)00239-4

K. Schäkel, R. Kannagi, B. Kniep, Y. Goto, C. Mitsuoka et al., 6-Sulfo LacNAc, a Novel Carbohydrate Modification of PSGL-1, Defines an Inflammatory Type of Human Dendritic Cells, Immunity, vol.17, issue.3, pp.289-301, 2002.
DOI : 10.1016/S1074-7613(02)00393-X

K. Schäkel, E. Mayer, C. Federle, M. Schmitz, G. Riethmüller et al., A novel dendritic cell population in human blood: one-step immunomagnetic isolation by a specific mAb (M-DC8) andin vitro priming of cytotoxic T lymphocytes, European Journal of Immunology, vol.90, issue.12, pp.4084-4093, 1998.
DOI : 10.1002/(SICI)1521-4141(199812)28:12<4084::AID-IMMU4084>3.0.CO;2-4

M. Schmitz, S. Zhao, Y. Deuse, K. Schäkel, R. Wehner et al., Tumoricidal Potential of Native Blood Dendritic Cells: Direct Tumor Cell Killing and Activation of NK Cell-Mediated Cytotoxicity, The Journal of Immunology, vol.174, issue.7, pp.4127-4134, 2005.
DOI : 10.4049/jimmunol.174.7.4127

M. Schmitz, S. Zhao, K. Schäkel, M. Bornhäuser, D. Ockert et al., Native human blood dendritic cells as potent effectors in antibodydependent cellular cytotoxicity, Blood, vol.100, pp.1502-1504, 2002.

J. Shi, K. Ikeda, N. Fujii, E. Kondo, K. Shinagawa et al., Activated human umbilical cord blood dendritic cells kill tumor cells without damaging normal hematological progenitor cells, Cancer Science, vol.163, issue.2, pp.127-133, 2005.
DOI : 10.1084/jem.177.2.295

G. Stary, C. Bangert, M. Tauber, R. Strohal, T. Kopp et al., Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells, The Journal of Experimental Medicine, vol.52, issue.6, pp.1441-1451, 2007.
DOI : 10.1016/0022-1759(96)00063-4

N. Vanderheyde, E. Aksoy, Z. Amraoui, P. Vandenabeele, M. Goldman et al., Tumoricidal Activity of Monocyte-Derived Dendritic Cells: Evidence for a Caspase-8-Dependent, Fas-Associated Death Domain-Independent Mechanism, The Journal of Immunology, vol.167, issue.7, pp.3565-3569, 2001.
DOI : 10.4049/jimmunol.167.7.3565

N. Vanderheyde, P. Vandenabeele, M. Goldman, and F. Willems, Distinct mechanisms are involved in tumoristatic and tumoricidal activities of monocyte-derived dendritic cells, Immunology Letters, vol.91, issue.2-3, pp.99-101, 2004.
DOI : 10.1016/j.imlet.2003.11.011

P. O. Vidalain, O. Azocar, B. Lamouille, A. Astier, C. Rabourdin-combe et al., Measles Virus Induces Functional TRAIL Production by Human Dendritic Cells, Journal of Virology, vol.74, issue.1, pp.556-559, 2000.
DOI : 10.1128/JVI.74.1.556-559.2000

P. O. Vidalain, O. Azocar, H. Yagita, C. Rabourdin-combe, and C. Servet-delprat, Cytotoxic Activity of Human Dendritic Cells Is Differentially Regulated by Double-Stranded RNA and CD40 Ligand, The Journal of Immunology, vol.167, issue.7, pp.3765-3772, 2001.
DOI : 10.4049/jimmunol.167.7.3765

R. Yang, D. Xu, A. Zhang, and A. Gruber, Immature dendritic cells kill ovarian carcinoma cells by a FAS/FASL pathway, enabling them to sensitize tumor-specific CTLs, International Journal of Cancer, vol.45, issue.3, pp.407-413, 2001.
DOI : 10.1002/ijc.1484

B. Bonnotte, N. Favre, S. Reveneau, O. Micheau, N. Droin et al., Cancer cell sensitization to Fas-mediated apoptosis by sodium butyrate, Cell Death and Differentiation, vol.5, issue.6, pp.480-487, 1998.
DOI : 10.1038/sj.cdd.4400371

S. Dikalov, M. Skatchkov, B. Fink, and E. Bassenge, Quantification of Superoxide Radicals and Peroxynitrite in Vascular Cells Using Oxidation of Sterically Hindered Hydroxylamines and Electron Spin Resonance, Nitric Oxide, vol.1, issue.5, pp.423-431, 1997.
DOI : 10.1006/niox.1997.0139

K. E. Wyche, S. S. Wang, K. K. Griendling, S. I. Dikalov, H. Austin et al., C242T CYBA Polymorphism of the NADPH Oxidase Is Associated With Reduced Respiratory Burst in Human Neutrophils, Hypertension, vol.43, issue.6, pp.1246-1251, 2004.
DOI : 10.1161/01.HYP.0000126579.50711.62

N. Kuzkaya, N. Weissmann, D. G. Harrison, and S. Dikalov, Interactions of Peroxynitrite, Tetrahydrobiopterin, Ascorbic Acid, and Thiols: IMPLICATIONS FOR UNCOUPLING ENDOTHELIAL NITRIC-OXIDE SYNTHASE, Journal of Biological Chemistry, vol.278, issue.25, pp.22546-22554, 2003.
DOI : 10.1074/jbc.M302227200

Y. Belkaid and G. Oldenhove, Tuning Microenvironments: Induction of Regulatory T Cells by Dendritic Cells, Immunity, vol.29, issue.3, pp.362-371, 2008.
DOI : 10.1016/j.immuni.2008.08.005

H. Shimamura, R. Cumberland, K. Hiroishi, S. C. Watkins, M. T. Lotze et al., Murine Dendritic Cell-Induced Tumor Apoptosis is Partially Mediated by Nitric Oxide, Journal of Immunotherapy, vol.25, issue.3, pp.226-234, 2002.
DOI : 10.1097/00002371-200205000-00005

A. Oudot, C. Martin, D. Busseuil, C. Vergely, L. Demaison et al., NADPH oxidases are in part responsible for increased cardiovascular superoxide production during aging, Free Radical Biology and Medicine, vol.40, issue.12, pp.2214-2222, 2006.
DOI : 10.1016/j.freeradbiomed.2006.02.020

S. Delemasure, P. Sicard, B. Lauzier, D. Moreau, C. Vergely et al., Acute Administration of Epirubicin Induces Myocardial Depression in Isolated Rat Heart and Production of Radical Species Evaluated by Electron Spin Resonance Spectroscopy, Journal of Cardiovascular Pharmacology, vol.50, issue.6, pp.647-653, 2007.
DOI : 10.1097/FJC.0b013e31815571f7

C. Bolton, G. S. Scott, T. Smith, and R. J. Flower, The acute and chronic phases of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE) are ameliorated by the peroxynitrite decomposition catalyst, 5,10,15,20-tetrakis(4-sulfonatophenyl)porphyrinatoiron (III) chloride, (FeTPPS), European Journal of Pharmacology, vol.601, issue.1-3, pp.20-88, 2008.
DOI : 10.1016/j.ejphar.2008.10.029

H. Duplain, C. Sartori, P. Dessen, P. Y. Jayet, M. Schwab et al., Stimulation of peroxynitrite catalysis improves insulin sensitivity in high fat diet-fed mice, The Journal of Physiology, vol.277, issue.16, pp.4011-4016, 2008.
DOI : 10.1113/jphysiol.2008.154302

S. Lancel, S. Tissier, S. Mordon, X. Marechal, F. Depontieu et al., Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats, Journal of the American College of Cardiology, vol.43, issue.12, pp.2348-2358, 2004.
DOI : 10.1016/j.jacc.2004.01.047

B. Lauzier, P. Sicard, O. Bouchot, S. Delemasure, D. Moreau et al., A peroxynitrite decomposition catalyst: FeTPPS confers cardioprotection during reperfusion after cardioplegic arrest in a working isolated rat heart model, Fundamental & Clinical Pharmacology, vol.230, issue.2, pp.173-180, 2007.
DOI : 10.1124/jpet.102.036871

S. S. Sharma, A. Dhar, and R. K. , FeTPPS protects against global cerebral ischemic-reperfusion injury in gerbils, Pharmacological Research, vol.55, issue.4, pp.335-342, 2007.
DOI : 10.1016/j.phrs.2007.01.002

S. Kurtulus, P. Tripathi, M. E. Moreno-fernandez, A. Sholl, J. D. Katz et al., Bcl-2 Allows Effector and Memory CD8+ T Cells To Tolerate Higher Expression of Bim, The Journal of Immunology, vol.186, issue.10, pp.5729-5737, 2011.
DOI : 10.4049/jimmunol.1100102

S. Wojciechowski, P. Tripathi, T. Bourdeau, L. Acero, H. L. Grimes et al., Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis, The Journal of Experimental Medicine, vol.71, issue.7, pp.1665-1675, 2007.
DOI : 10.1073/pnas.95.7.3810

K. S. Schluns, W. C. Kieper, S. C. Jameson, and L. Lefrançois, Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo, Nature Immunology, vol.1, issue.5, pp.426-432, 2000.
DOI : 10.1038/80868

D. Gabrilovich, Mechanisms and functional significance of tumour-induced dendritic-cell defects, Nature Reviews Immunology, vol.172, issue.12, pp.941-952, 2004.
DOI : 10.1073/pnas.172384399

G. A. Rabinovich, D. Gabrilovich, and E. M. Sotomayor, Immunosuppressive Strategies that are Mediated by Tumor Cells, Annual Review of Immunology, vol.25, issue.1, pp.267-296, 2007.
DOI : 10.1146/annurev.immunol.25.022106.141609

B. Bonnotte, M. Crittenden, N. Larmonier, M. Gough, and R. G. Vile, MIP-3?? Transfection into a Rodent Tumor Cell Line Increases Intratumoral Dendritic Cell Infiltration but Enhances (Facilitates) Tumor Growth and Decreases Immunogenicity, The Journal of Immunology, vol.173, issue.8, pp.4929-4935, 2004.
DOI : 10.4049/jimmunol.173.8.4929